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Objective: This study focuses on the growth-promoting and migration-enhancing role
that Clostridial collagenase plays in vitro and in vivo. Methods: Fori nvitro studies,
biosynthesized extracellular matrices were treated with purified Clostridial collagenase,
nonspecific proteases, or buffer controls. Keratinocytes were subsequently plated upon
these matrices in the presence or absence of Clostridial collagenase and/or heparin-
binding epidermal-like growth factor, and cell proliferation and migration were quanti-
fied. To examine the effects of Clostridial collagenase in vivo, we performed a double-
blind study of full-thickness wounds on the backs of Yucatan Micropigs, testing the
effects of purified Clostridial collagenase, Regranex (PDGF-BB), and Solosite (car-
boxymethyl cellulose) on wound healing. Results: In vitro studies: Matrix pretreatment
with Clostridial collagenase stimulates a 2-fold increase in proliferation and postinjury
migration; when Clostridial collagenase and/or heparin-binding epidermal-like growth
factor are added to the growth media, there is an additional doubling of growth and
migration, yielding approximately 5-fold enhancement of keratinocyte proliferation and
migration. Papain-urea treatment under similar conditions results in a 50% decrease in
cell number over a 1-week time course. In vivo studies: By all parameters measured,
including granulation tissue formation, inflammation, re-epithelization, and time to
wound closure, purified Clostridial collagenase was superior (analysis of variance,
P<.05) to other treatments tested. Conclusion: On the basis of these findings, we
concluded that Clostridial collagenase stimulates keratinocyte cellular responses to in-
jury in vitro and may represent a novel therapeutic approach for promotion of wound
healing in vivo.
The keratinocyte basement membrane serves as a scaffold and a macromolecular sig-
naling matrix responsible for regulating cell behavior during development, adult life, and
wound healing. Synthesized and organized by keratinocytes, matrix components play a
pivotal role in orchestrating epithelial proliferation,1 adhesion,2 and migration,3 includ-
ing the cellular responses to injury. Glycoproteins and proteoglycans not only provide a
physical scaffold for epithelial cells but also can bind and sequester signaling molecules,
including members of the epidermal growth factor (EGF),4 fibroblast and keratinocyte
growth factor,5,6 and transforming growth factor families.7 Keratinocytes transduce signals
from these matrix-bound or soluble growth factors through their high-affinity tyrosine and
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serine/threonine kinase growth factor receptors, thereby completing this biochemical sig-
naling cascade.
Keratinocyteresponsivenesstotheextracellularmatrixinvolvescontrollingtheexpres-
sion, activation, and localization of the receptors that transduce matrix-associated signals.
Fore xample, the activation and relocation of integrin receptors in response to injury is cru-
cialtotheinitiationofwoundhealing.Inthewoundarea,keratinocytescomeincontactwith
the newly exposed dermal matrix, which contains Type I collagen and laminin 5 not found
in the intact keratinocyte basement membrane, typically composed of collagen IV , laminin
1, fibronectin, and other molecules.8,9 The newly exposed dermal matrix components bind
and activate the α2β1 integrin receptor, causing its relocation to the site of injury, thus
allowing keratinocytes to adhere to the exposed dermal matrix and begin migration into the
wound area.10 Expression of αVβ5 integrin is also induced at the wound edge, and likewise
promotes migration.11 Interestingly, knockout mice lacking the β1 integrin subunit show
abnormal keratinocyte morphology and are highly deficient in wound healing because of
defects in adhesion, migration, and proliferation.12
In addition to the modifications seen in the integrin receptor repertoire during wound
healing,injuredkeratinocytesreleasegrowthfactorsandmatrixmetalloproteinases(MMPs)
tostimulatetheirintegrin-mediatedmigration.13,14 Growthfactors,suchasheparin-binding
epidermal growth factor (HbEGF), are produced by keratinocytes in a membrane-tethered
form. In response to injury, HbEGF is cleaved and released by extracellular MMP-3, or
Stromelysin I.15 Keratinocytes also produce MMP-1, MMP-2 and MMP-9, all of which
help to remodel the matrix, allowing cells to migrate into and close the wound.9,16–18 MMP
production is stimulated by the presence of target substrates and growth factors,.9,16,19–21
and MMP-1 can also be bound by integrin α2β1 for targeted collagen degradation.22 When
healingiscompletedandthewoundisclosed,theremodeledmatrixsignalsthroughintegrins
to downregulate keratinocyte MMP and growth factor production.9
Undernormalcircumstances,thedynamicexchangebetweenkeratinocytesandmatrix
results in complete wound closure and regeneration of the dermis and epidermis. However,
some wounds fail to heal normally and become chronic. Chronic wounds exhibit a healing
profile different from that for normal acute wounds,23,24 remaining in an inflamed state
for protracted periods of time. Chronic wounds are frequently exacerbated by intrinsic
factors such as excess inflammatory cytokines and poor vascularization/ischemia.25 The
deregulation of integrins26 and overabundance of MMPs,27–29 as well as the lack of tissue-
specific inhibitors of MMPs,30 can also give rise to chronic wounds. These wounds almost
always require clinical intervention in order for healing to occur.
Because of the fluctuating balance of activating and inhibiting signals that are induced
during wound healing, we question whether exogenous application of factors known to
regulate normal healing might accelerate the acute healing process, or activate the healing
of chronic wounds. We have previously shown that collagenase from Clostridium bacteria
promotes the migration and proliferation of vascular endothelial cells and keratinocytes31
after injury, with an efficiency more than twice that of mammalian collagenase. While
mammalian enzymes cleave collagen at one site to produce one-quarter and three-quarter
size fragments,32 Clostridial collagenase cleaves all 3 helical domains to produce several
breakdown products.33,34
There has also been a great deal of interest in the papaya-derived protease papain,
initially reported as a wound treatment 4 decades ago.35 Research is still ongoing into the
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precise role this enzyme may have in promoting healing,36 though it is currently classified
as an enzymatic debriding agent. We have examined its effects on keratinocytes in vitro
to determine whether its clinical efficacy may be due to the promotion of keratinocyte
proliferationand/ormotility.WehavealsorevisitedtheClostridialcollagenaseexperiments
on keratinocytes, and expanded our investigation to include an in vivo wound healing assay
on miniature swine. In our in vivo study, we have compared Clostridial collagenase with 2
commerciallyavailablepreparations,Regranex,theactiveingredientofwhichisPDGF-BB,
andSolosite,across-linkedcarboxymethylcellulose–basedhydrogelthatmaintainsamoist
healing environment, as well as a sterile gauze negative control. Overall, we hope to clarify
the role that Clostridial collagenase may play as a wound healing agent.
METHODS
Cells
Epithelial keratinocytes isolated from normal human epidermal keratinocyte (NHEK)
were purchased from Clonetics (Walkersville, Md) and cultured in complete Keratinocyte
Growth Medium (KGM, Clonetics) in 175 cm2 tissue culture flasks (Costar) as previously
described.31Cellswerepassagedwithtrypsin,quenchedwithmediumcontaining5%bovine
calf serum, rinsed in phosphate-buffered saline, and replated in KGM at a ratio of 1:4 for
cell propagation and at specified cell numbers for all experiments. Cells were fed every
other day by complete media exchange with fresh KGM. In all experiments where soluble
factors were added to the growth media, these factors were added at the time of cell plating,
and replenished as cells were fed on alternate days. HbEGF was obtained from Oncogene,
San Diego, Calif.
Matrix Preparations
Matrixpreparationsweremadeaspreviouslydescribed.31 Briefly,capillaryendothelialcells
at 10 days postconfluence were released from their matrix with DOC buffer (0.5% sodium
deoxycholate, 0.02 M Tris-Cl [pH 8.0], 0.015 M NaCl, 0.001 M EGTA [pH 7.0], 0.001 M
phenylmethyl sulfonyl fluoride), and the remaining matrix was washed with phosphate-
bufferedsaline.Enzymesusedformatrixdigestionsweredilutedincalcium-bufferedsaline,
foratotalof250µLperwellina24-wellplate.Digestionswereperformedat37◦Cfor1hour
in a cell culture incubator. Following digestion or control treatment with calcium-buffered
saline alone, the matrix was first washed with phosphate-buffered saline and then allowed
to equilibrate in KGM for 15 minutes at 37◦C. The KGM was removed, and NHEK cells
were released from flasks with trypsin, counted, and plated onto the matrix in fresh KGM.
Earlier published experiments indicate that the enzyme doses used for matrix treatment do
not affect the plating efficiency of the keratinocytes.31
Enzymes
Enzymes used for extracellular matrix digestion were purified collagenase from Clostrid-
ium,c rude collagenase, and clostripain (Advanced Biofactures Corp, Lynbrook, NY), as in
previousexperiments.31 Amixtureofpapainand1%urea(BecktonDickinson,Sparks,Md)
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was alsotested,36–39 withorwithouttheadditionofchlorophyllin(BecktonDickinson).40–42
All treatment doses are given in standard units of enzymatic activity.
Cell proliferation assay
Growthassayswereperformedaspreviouslydescribed.31 Briefly,NHEKcellswerereleased
fromthematrixwithtrypsin,dilutedinIsotonIIelectrolytebuffer(Beckman,Fullerton,CA)
forcountinginaCoulterCountermodelZF(CoulterElectronics,Miami,Fla).Experimental
conditions were plated in duplicate, and each sample was counted twice. Each condition
was tested in at least 3 separate experiments. Data were recorded manually and analyzed in
Microsoft Excel (Microsoft, San Jose, Calif).
Cell migration assay
For motility studies, matrix was prepared on 10 mm2 glass cover slips (Corning, Big Flats,
NY) as described above. NHEK cells were plated at confluence on the resultant matrix and
allowedtoattachovernight.Cellmonolayerswereinjuredwithafire-polishedpasteurpipette
to create a narrow scratch wound. The wounded populations were monitored through time-
lapse imaging, as previously described.43 Relative motility was calculated by comparing
the change in area covered by cells in the same sized viewing field over the same period of
time for different treatment conditions.
Wound healing study
A full-thickness wound healing study on swine was conducted by North American Sci-
ence Associates (NAMSA), Northwood, Ohio, in accordance with the National Insti-
tutes of Health guidelines for the treatment of laboratory animals. Treatments tested were
(1) Clostridium bacterial collagenase in ointment, (2) Regranex gel, (3) Solosite gel, and
(4) dry sterile gauze as a negative control. The study was conducted on 8 healthy female
adult Micro-Yucatan Miniature swine (Sus scrofa domesticus), selected on the basis of their
use in other published research and their similarity of wound healing to humans. Each an-
imal received eight 2-cm diameter full-thickness wounds on its back while under general
anesthesia. Pressure was applied to stop bleeding before any treatment or dressing was
affixed on Day 0. Two wounds on each pig were dressed with each of the 4 treatment condi-
tions,withlocations(cranialtocaudal)randomized.Clostridialcollagenasewaspreparedat
1000 U/g of ointment. Standard commercial preparations of Regranex and Solosite were
used. Ointments were applied at 0.25 g/d, according to the directions for use of the com-
mercial products. Treated wounds were covered with OpSite Flexgrid, a transparent wound
dressing. The dry control wounds were covered with sterile gauze. All bandages and dress-
ings were changed daily. The gauze dressings were removed carefully by a veterinarian,
who noted minimal disruption to the wounds due to moisture from wound exudation. Ob-
servations were recorded daily for each wound, such as the diameter, color, exudation, and
epithelization, in a double-blinded manner. Wound area was calculated from tracings made
on transparent plastic during daily examinations. Following daily observations, the wound
area was gently rinsed with sterile saline and dried with sterile gauze to permit adhesion of
the new dressing. Vigorous flushing of the wound itself was not performed.
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Table 1. Cell proliferation in vitro, Day 7∗
Without soluble enzyme With soluble enzyme
Untreated matrix 1.0 1.6
Purified collagenase 2.3 4.5
Purified collagenase + HbEGF 2.9 4.9
HbEGF alone 1.4 2.6
Crude collagenase 1.2 2.3
Clostripain 1.1 2.0
Papain-Urea/chlorophyllin 0.5
∗HbEGFindicatesheparin-bindingepidermalgrowthfactor.Resultsshownarethecomparativeeffectsofmatrixpretreatment
and soluble factors on proliferation. Soluble enzymes are the same as those used for matrix pretreatment; cells plated on
untreated matrix received soluble Clostridial collagenase. All soluble enzymes were added at 16 U/mL in the culture media.
HbEGF was applied both in the presence and absence of soluble enzyme in the indicated samples. The number of cells in
the control condition was set equal to one, and all other results are shown in relation to this control. For each condition, the
average of at least 3 separate experiments is shown. All standard deviations are less than 0.05.
At the conclusion of the study, each wound was excised, with a 1 to 2 cm border of
intact skin, for histological processing. Each sample was fixed in 10% neutral buffered
formalin, embedded, sectioned, and stained with hematoxylin and eosin. Two sections were
taken from each wound sample: one across the central diameter of the wound and one
parallel section from the side halfway to the edge of the original defect. Epithelization was
recorded from the central section of each wound as the percentage of the defect covered by
well-defined dermal epithelium.
RESULTS
In vitro proliferation
To simulate the in vivo basement membrane of keratinocytes, we used the biomatrix
generated by confluent capillary endothelial cells, which has been shown to contain fi-
bronectin, laminin, and collagen of types I, III, and IV .44 Treatment of the endothelial-
produced biomatrix with purified bacterial collagenase prior to plating caused an approx-
imate doubling in keratinocyte proliferation as compared to cells on untreated matrix
(Table 1). The addition of HbEGF14,31,45 to the culture media was also tested in prolif-
eration assays. The addition of 0.1 ng/mL HbEGF to cells on untreated matrix caused
a 1.4-fold increase in proliferation over controls after 7 days, but when added to cells
growing on collagenase-digested matrix, proliferation nearly tripled. Treatment of the ma-
trix with crude collagenase, which contains other nonspecific proteases, caused only a
slight increase in cell number over controls. Clostripain, a purified nonspecific protease,
produced an even smaller increase in proliferation. Pretreatment of the matrix with urea
and papain,36,38,46 with or without chlorophyllin, diminished cell proliferation to half of
control numbers. We next asked whether addition of collagenase to the growth media
would affect proliferation, alone or in combination with matrix pretreatment (Table 1).
On untreated matrix, incubating cells with 16 U/mL soluble collagenase in the growth
medium resulted in a 1.6-fold increase in proliferation. When cells were grown on matrix
pretreated with collagenase, and incubated with the same dose of soluble enzyme, total
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Figure 1. Keratinocyte motility in vitro. This figure shows the relative ability of keratinocytes to
spread and crawl to close a narrow in vitro wound. A population grown on untreated matrix in
normal media (A and B) and a population of the same density on matrix treated with collagenase
and with collagenase present in the media (C and D) are shown just after wounding (A and C) and
120minutesincubationpostwounding(BandD).Scalebarequals50µm.Timelapsedigitalimages,
available as Quicktime movies, can be viewed at http://www.journalofburnsandwounds.com. Panel
Eshowsthequantifiedrelativemotilityofcontrol(n=2)andtreated(n=2)populationsduringthe
initial 30 minutes after wounding, with the control set equal to 1. Error bars represent the standard
error of the mean (P<.01, Student t test).
proliferation was 4.5 times that for control, and nearly double the result seen with treated
matrix alone.
In vitro motility
To assess the effect of bacterial collagenase on cell motility, we used digital imaging mi-
croscopy to monitor the rate at which a confluent cell monolayer is able to close a narrow
wound. In all conditions, keratinocytes at the wound edge first elaborate a membrane fan,
then detach the trailing edge, and finally pull the nucleus and cell body forward toward the
leading edge. As this happens, cells further from the wound edge spread to fill the newly
available space. On matrix pretreated with collagenase, the cells at the leading edge extend
amuchlongermembranefanbeforetranslocatingtherestofthecell,thuscoveringagreater
distance in a shorter period of time (Figs 1C and 1D). Overall, keratinocyte motility was
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Video 1. Keratinocytes on untreated matrix crawling in response to injury.
Video 2. Keratinocytes on collagenase-treated matrix, with collagenase and
heparin-binding epidermal growth factor in the media, crawling in response
to injury.
increased nearly 8-fold over controls when assayed on treated matrix, in the presence of
HbEGF and soluble collagenase (Fig 1E). Time-lapse digital images can be viewed as
Quicktime movies at http://www.journalofburnsandwounds.com.
In vivo
In order to determine whether the enhancement of proliferation and migration seen in
vitro would translate into the promotion of healing in vivo, a double-blinded study of full-
thickness wounds on Yucatan Micropigs was conducted by NAMSA. Superficial observa-
tions of wound color and exudation did not vary markedly among the treatment conditions.
Granulation tissue developed more slowly in control wounds than in treated wounds, but no
obvious difference was noted between treatment conditions. By analysis of the wound area
asapercentageoftheoriginalwound,itwasfoundthatcollagenaseacceleratesoverallheal-
ing (Fig 2). The differences among the treatment conditions became statistically significant
(analysis of variance, P<.05) beginning on Day 6 of the trial, when the wound area began
to decrease. Differences between collagenase and Solosite or collagenase and Regranex
became significant (Tukey test, P< .05) from Day 7 onward. The difference between the
collagenase condition and the control condition was significant (Tukey test, P<.05) from
Day 4. The area of the wound covered by new epithelial tissue in the terminal histology
samples was also greater with collagenase treatment than with Regranex, Solosite, or the
dry control (Fig 3). This improved re-epithelization was accompanied by a decrease in
observed granulation tissue in the collagenase-treated wounds (not shown). The improved
condition of the collagenase-treated wounds can be seen in photographs taken on Day 10
after wounding (Fig 4).
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Figure 2. Percentage healing of in vivo wounds. This chart shows
the average percentage of wound closure, based on the origi-
nal wound area, on each day of the experimental treatment with
Clostridial collagenase, Regranex, Solosite, or a dry, sterile gauze
control(n=16foreachcondition).Errorbarsrepresentthestandard
errorofthemean.BeginningonDay6,whenhealingbegantoresult
in a decreased wound size, there was a statistically significant dif-
ferenceamongthetreatmentgroups(analysisofvariance,P<.05),
and between each individual treatment and the sterile gauze control
(Tukey test, P<.05). From Day 7 onwards, the difference between
collagenase and each of the other 2 treatments is also significant
(Tukey test, P<.05), though Solosite and Regranex did not differ
significantly from each other.
DISCUSSION
Through our experiments, we have reaffirmed that pretreatment of a biosynthesized ex-
tracellular matrix by Clostridial collagenase promotes human keratinocyte responses to
injury. Collagenase acts through multiple signaling pathways, increasing proliferation and
migration in vitro. It is effective via pretreatment of the matrix and/or its presence in the
growth media. Interestingly, the effects of collagenase are strongly potentiated by inclusion
of HbEGF, which is prevalent in in vivo wounds.13,14 Through a combination of matrix
pretreatment and addition of soluble collagenase and/or HbEGF in the growth media, ker-
atinocyte proliferation can be potentiated 5-fold. Keratinocyte migration following injury
in vitro is similarly enhanced. Papain-urea, alone or in combination with chlorophyllin,
currently in clinical use for enzymatic debridement of wounds,36 inhibited keratinocyte
proliferation in vitro, over a wide range of tested doses. Importantly, purified Clostridial
collagenase also promoted the cellular responses to injury in vivo, resulting in reduced
granulation tissue, increased rates of re-epithelization, and a shorter interval to wound
closure.
Pretreatmentofbiosynthesizedextracellularmatrix,47 whichisanalogoustothehuman
keratinocyte basement membrane, with Clostridial collagenase promoted cell proliferation
(Table 1) and migration (Fig 1). These results are supported by earlier work from this
laboratory on vascular endothelial cells migrating in response to injury.44,48 In addition,
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Figure 3. Re-epithelization of in vivo wounds. This
chart shows the percentage of re-epithelization of in vivo
woundstreatedwithcollagenase,Regranex,Solosite,and
ad ry, sterile gauze control (n=16 for each condition),
based on histological samples prepared at the conclusion
of the study on Day 11 (P<.01, analysis of variance).
endogenous collagenase has been shown to promote keratinocyte migration in vitro.16,49
Collectively, these results point to the important role that collagenase and other MMPs play
in modulating cellular responses to injury and wound healing.
Inclusion of Clostridial collagenase in the growth media, alone or in addition to ma-
trix pretreatment, was also able to stimulate the keratinocyte response to injury (Table 1).
Furthermore, HbEGF stimulated keratinocyte proliferation in vitro, as well as potentiated
the migration-enhancing effects of Clostridial collagenase (Table 1). It has been shown in
vitro that stromelysin, or MMP-3,15 is able to cleave HbEGF at the juxtamembrane site,
releasing the mature, soluble form of the growth factor to signal in a paracrine or juxtacrine
fashion. Interestingly, MMP-3 cleaves HbEGF successfully, but MMP-2 and MMP-9 do
not. Other in vitro studies have shown that membrane-type MMP-1 can cleave and acti-
vate pro-αV, -3, and -5 integrins.49,50 Through its processing of the αV integrin subunit,
MT-MMP-1 prevents the suppression of the collagen-binding α2β1 receptor by αVβ3,51
with the overall effect promoting migration on Type I collagen. These data indicate that
membrane-associatedgrowthfactorsandreceptorscanbereleasedand/oractivatedthrough
MMP action. Similarly, by releasing and activating endogenous promoters of growth and
migration,Clostridialcollagenasemaybeabletoinducethekeratinocyteresponsestoinjury.
OurinvivowoundhealingstudyonswineextendsourinvitrofindingsthatClostridial
collagenase promotes epithelial cell proliferation and migration by revealing that direct
application of purified Clostridial collagenase to full-thickness wounds promotes healing
and improves wound health as compared to other commercial preparations tested or un-
treated controls. There are numerous reports indicating that several types of collagenase
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Figure 4. Comparison of in vivo wounds on Day 10. This figure shows 4 wounds from each of
the treatment groups, photographed on Day 10 of the study. The wounds treated with Clostridial
collagenase show the least fluid exudation and the greatest re-epithelization.
have already been tested and are in clinical use as enzymatic debriding agents.52–56 From
the studies using preparations of Clostridial collagenase,57,58 there is ample evidence to
indicate that collagenase not only successfully debrides wounds but also hastens wound
closure.53 Altogether, these results point to a promising role for collagenase in promoting
acute and chronic wound healing.
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